Sector ratings Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX 11:29:52 2026-08-21 EDT			5-day change	1st Jan Change
550.61 ^USD	+1.92%		+9.12%	+21.73%

08-12	Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says	MT
08-11	Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $633 From $610, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
VERTEX PHARMACEUTICALS INCORPORATED	137B		AA
ELI LILLY AND COMPANY	1,109B		A
JOHNSON & JOHNSON	644B	-	BBB	-	-
ABBVIE INC.	463B		AA		-
ROCHE HOLDING AG	371B		AA
NOVARTIS AG	301B		AAA
ASTRAZENECA PLC	256B		A
AMGEN INC.	234B		A
NOVO NORDISK A/S	205B		A
GILEAD SCIENCES, INC.	178B		AA
PFIZER INC.	158B		A
BRISTOL-MYERS SQUIBB COMPANY	134B		A
SANOFI	109B		AA
GSK PLC	105B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	73.59B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	58.59B		AA
BAYER AG	55.78B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	48.45B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	42.89B		-
HALEON PLC	43.25B		AA
Average	236.33B		AA
Weighted average by Cap.			AA